The DOI matches its Crossref record; 41 of the 41 references it cites were found in a registry or an index.
Systematic meta-review of depot antipsychotic drugs for people with schizophrenia
Open accessAbstract
Background: Long-acting depot antipsychotic medication is a widely used treatment for schizophrenia. Aims: To synthesise relevant systematic Cochrane reviews. Method: The Cochrane Database was searched and summary data were extracted from randomised controlled clinical trials of depots. Results: Standard dose depot v. placebo resulted in significantly less relapse but more movement disorders. Those on depots (v. oral drugs) showed more global change on one outcome measure; relapse and adverse effects showed no difference. Comparisons showed no convincing advantages for one depot over another. Conclusions: Depot antipsychotics are safe and effective. They may confer a small benefit over oral drugs on global outcome. Those for whom depots are most indicated may not be represented. Large studies are required to discern differences in relapse rates and long-term adverse effects, and data on satisfaction, quality of life and economics.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Hamilton, M. (1960) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.23.1.56 · Cited by 32,817
The Brief Psychiatric Rating Scale.
Overall, J. E., & Gorham, D. R. (1962) · Psychological Reports · doi:10.2466/pr0.1962.10.3.799 · Cited by 11,090
(1976) · Medical Entomology and Zoology · Cited by 8,899
Schulz (1995) · doi:10.1001/jama.1995.03520290060030 · Cited by 5,634
A RATING SCALE FOR EXTRAPYRAMIDAL SIDE EFFECTS
SIMPSON, G. M., B., M., B., G., ANGUS, J. W. S., P., F. R. C., & M., D. P. (1970) · Acta Psychiatrica Scandinavica · doi:10.1111/j.1600-0447.1970.tb02066.x · Cited by 3,264
Improving the Quality of Reporting of Randomized Controlled Trials: The CONSORT Statement
Begg, C. (1996) · JAMA · doi:10.1001/jama.1996.03540080059030 · Cited by 3,127
(1958) · Journal of the American Pharmaceutical Association (Scientific ed.) · doi:10.1002/jps.3030470133 · Cited by 2,489
Lingjærde, O., Ahlfors, U. G., Bech, P., Dencker, S. J., & Elgen, K. (1987) · Acta Psychiatrica Scandinavica · doi:10.1111/j.1600-0447.1987.tb10566.x · Cited by 1,705
A COMPREHENSIVE PSYCHOPATHOLOGICAL RATING SCALE
Åsberg, M., Montgomery, S. A., Perris, C., Schalling, D., & Sedvall, G. (1978) · Acta Psychiatrica Scandinavica · doi:10.1111/j.1600-0447.1978.tb02357.x · Cited by 1,326
Determinants of Medication Compliance in Schizophrenia: Empirical and Clinical Findings
Fenton, W. S., Blyler, C. R., & Heinssen, R. K. (1997) · Schizophrenia Bulletin · doi:10.1093/schbul/23.4.637 · Cited by 957
Bias in treatment assignment in controlled clinical trials
Chalmers, T. C., Celano, P., Sacks, H. S., & Smith, H. (1983) · New England Journal of Medicine · doi:10.1056/nejm198312013092204 · Cited by 864
Cha, M., Eastwaad, S., Hartan, R., Maher, D., Olkin, I., Pitkin, R., Rennie, D., Schulz, K. F., Simel, D. L., & Straup, D. F. (1996) · Cited by 737
Cost of Relapse in Schizophrenia
Weiden, P. J., & Olfson, M. (1995) · Schizophrenia Bulletin · doi:10.1093/schbul/21.3.419 · Cited by 666
Jadad, A. R., Cook, D. J., Jones, A., Klassen, T. P., Tugwell, P., Moher, M., & Moher, D. (1998) · JAMA · doi:10.1001/jama.280.3.278 · Cited by 534
[The problem of therapeutic efficacy indices. 3. Comparison of the indices and their use].
Boissel, J., Cucherat, M., Li, W., Châtellier, G., Gueyffier, F., Buyse, M. E., Boutitie, F., Nony, P., Haugh, M., & Mignot, G. (1999) · PubMed · Cited by 533
Content and quality of 2000 controlled trials in schizophrenia over 50 years
Thornley, B., & Adams, C. (1998) · BMJ · doi:10.1136/bmj.317.7167.1181 · Cited by 364
Self-citationNOSIE-30: A Treatment-Sensitive Ward Behavior Scale
Honigfeld, G., Gillis, R. D., & Klett, C. J. (1966) · Psychological Reports · doi:10.2466/pr0.1966.19.1.180 · Cited by 353
Wolfstein, &. (1905) · The Journal of Nervous and Mental Disease · doi:10.1097/00005053-190502000-00009 · Cited by 344
Guidelines for depot antipsychotic treatment in schizophrenia
Kane, J. M., Aguglia, E., Altamura, A. C., Gutierrez, J. L. A., Brunello, N., Fleischhacker, W. W., Gaebel, W., Gerlach, J., Guelfi, J.-D., Kissling, W., et al. (1998) · European Neuropsychopharmacology · doi:10.1016/s0924-977x(97)00045-x · Cited by 332
Depot Antipsychotic Drugs: Place in Therapy
Davis, J. M., Metalon, L., Watanabe, M. D., & Blake, L. (1994) · Drugs · doi:10.2165/00003495-199447050-00004 · Cited by 295
Hirsch, S. R., Gaind, R., Rohde, P. D., Stevens, B. C., & Wing, J. K. (1973) · BMJ · doi:10.1136/bmj.1.5854.633 · Cited by 259
A Simple and Reliable Subclassification of Chronic Schizophrenia
Wing, J. K. (1961) · Journal of Mental Science · doi:10.1192/bjp.107.450.862 · Cited by 253
Depot neuroleptics in relapse prevention: advantages and disadvantages
Gerlach, J. (1995) · International Clinical Psychopharmacology · doi:10.1097/00004850-199501005-00004 · Cited by 227
Depot perphenazine decanoate and enanthate for schizophrenia
David, A., Quraishi, S. N., & Rathbone, J. (2005) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd001717.pub2 · Cited by 196
Self-citationDepot fluphenazine decanoate and enanthate for schizophrenia
David, A., Adams, C. E., Eisenbruch, M., Quraishi, S. N., & Rathbone, J. (2004) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd000307 · Cited by 194
Self-citationZuclopenthixol decanoate for schizophrenia and other serious mental illnesses
da Silva Freire Coutinho, E., Fenton, M., & Quraishi, S. N. (1999) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd001164 · Cited by 188
Self-citationSystematic review of patient and nurse attitudes to depot antipsychotic medication
Walburn, J., Gray, R., Gournay, K., Quraishi, S., & David, A. S. (2001) · British Journal of Psychiatry · doi:10.1192/bjp.179.4.300 · Cited by 187
Self-citationDepot flupenthixol decanoate for schizophrenia or other similar psychotic disorders
David, A., Adams, C. E., & Quraishi, S. N. (1999) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd001470 · Cited by 180
Self-citationPragmatic randomised controlled trials in psychiatry
Hotopf, M., Churchill, R., & Lewis, G. (1999) · British Journal of Psychiatry · doi:10.1192/bjp.175.3.217 · Cited by 165
Depot neuroleptic therapy: an underutilized treatment option.
Glazer, W. M., & Kane, J. M. (1992) · PubMed · Cited by 146
Long Term Depot Antipsychotics
Barnes, T. R. E., & Curson, D. A. (1994) · Drug Safety · doi:10.2165/00002018-199410060-00005 · Cited by 130
Treatment Compliance and the Therapeutic Alliance
Blackwell, B. (1997) · Cited by 110
The Natural Course of Schizophrenia and Effective Maintenance Drug Treatment
Davis, J. M., & Andriukaitis, S. M. (1986) · Journal of Clinical Psychopharmacology · doi:10.1097/00004714-198602001-00002 · Cited by 98
Development of a schizophrenia scale sensitive to change
Montgomery, S., Taylor, P. J., & Montgomery, D. (1978) · Neuropharmacology · doi:10.1016/0028-3908(78)90038-2 · Cited by 90
Treatment Compliance and the Therapeutic Alliance
Munetz, M. R. (1998) · Psychiatric Services · doi:10.1176/ps.49.11.1496 · Cited by 81
Publication bias and the integrity of psychiatry research
Gilbody, S. M., & Song, F. (2000) · Psychological Medicine · doi:10.1017/s0033291700001732 · Cited by 65
Depot haloperidol decanoate for schizophrenia
Quraishi, S. N., David, A. S., Brasil, M. A. A., & Alheira, F. V. (1999) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd001361 · Cited by 45
Self-citationAn evaluation of primary alcoholics with histories of violence.
Schuckit, M. A., & Russell, J. W. (1984) · PubMed · Cited by 33
Depot fluspirilene for schizophrenia
Abhijnhan, A., Adams, C. E., David, A. S., & Ozbilen, M. (2007) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd001718.pub2 · Cited by 28
Self-citationA brief history of depot neuroleptics.
Gm, S. (1984) · PubMed · Cited by 28
Depot pipotiazine palmitate and undecylenate for schizophrenia
Dinesh, M., David, A. S., & Quraishi, S. N. (2004) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd001720.pub2 · Cited by 14
Self-citation
Cited by
Tiihonen, J., Haukka, J., Taylor, M., Haddad, P. M., Patel, M. X., & Korhonen, P. (2011) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2011.10081224 · Cited by 619
Barnes, T. R., Drake, R., Paton, C., Cooper, S. J., Deakin, B., Ferrier, I. N., Gregory, C. J., Haddad, P. M., Howes, O. D., Jones, I., et al. (2020) · Journal of Psychopharmacology · doi:10.1177/0269881119889296 · Cited by 606
Kane, J. M., Eerdekens, M., Lindenmayer, J.-P., Keith, S. J., Lesem, M., & Karcher, K. (2003) · American Journal of Psychiatry · doi:10.1176/appi.ajp.160.6.1125 · Cited by 489
Leucht, C., Heres, S., Kane, J. M., Kissling, W., Davis, J. M., & Leucht, S. (2011) · Schizophrenia Research · doi:10.1016/j.schres.2010.11.020 · Cited by 419
Hasan, A., Falkai, P., Wobrock, T., Lieberman, J., Glenthoj, B., Gattaz, W. F., Thibaut, F., Möller, H.-J., & WFSBP Task force on Treatment Guidelines for Schizophrenia (2013) · The World Journal of Biological Psychiatry · doi:10.3109/15622975.2012.739708 · Cited by 416
Metadata
- Authors
- Adams, C. E., Fenton, M. K. P., Quraishi, S., & David, A. S.
- Venue
- British Journal of Psychiatry
- Publisher
- Royal College of Psychiatrists
- Published
- 2001-10
- Volume
- 179
- Issue
- 4
- Pages
- 290-299
- ISSN
- 0007-1250 (ISSN-L)
- 1472-1465
- OpenAlex
- W2099226437
- Cited by
- 288
- References
- 41
- FWCI
- 6.28
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.